Syntagon Overview

  • Founded
  • 1998
  • Status
  • Acquired/​Merged
  • Employees
  • 8
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 1

Syntagon General Information


Manufacturer and developer of drugs and chemicals. The company involved in contract development and manufacturing organization (CDMO) and testing pharmaceutical ingredients supporting clinical trials and launched products.

Contact Information

Ownership Status
Financing Status
Private Equity-Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • Box 2073
  • 151 02 Södertälje
  • Sweden
+46 08-554 000 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Syntagon Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Syntagon‘s full profile, request access.

Request a free trial

Syntagon Executive Team (2)

Name Title Board Seat Contact Info
Michael Lofthagen Chief Executive Officer & Co-Founder
Paul Alhadeff Co-Founder & General Manager
To view Syntagon’s complete executive team members history, request access »

Syntagon Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial